A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Malignancies
Interventions: DRUG: INCAGN01949|DRUG: Nivolumab|DRUG: Ipilimumab
Sponsor: Incyte Biosciences International Sàrl